...We Welcome You To The Resverlogix HUB On AGORACOM!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** Trial is Fully Enrolled and Top-Line Results Expected Q1 2019

Free
Message: Isreal Deal

"total royalty payments are estimated to potentially reach in excess of US$100 million...."

What an ugly way to phrase something.....it could have been stated a much clearer manner, like

"total royalty payents could exceed $100 million"  

Share
New Message
Please login to post a reply